Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease

Deok Hoon Kong, Jae Wan Jung, Keun Na, Seul Ki Jeong, Young Ki Paik, Se Hui Jung, In Bum Suh, Young Myeong Kim, Kwon Soo Ha

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

For minimizing systemic experimental variation in the analysis of antibody array data, we developed a novel median-centered/IgM-tagged-internal standard (TIS) assay normalization using median-centering and TIS assay-based determination of serum IgM concentrations. We evaluated five normalization methods by analyzing correlation coefficients and coefficients of variation for six serum proteins using human serum samples from normal controls (n= 25) and patients with liver cirrhosis (n= 25) or hepatocellular carcinoma (HCC; n= 29). Median-centered normalization improved correlation coefficients, while IgM-based normalizations improved coefficients of variation. The TIS assay was more efficient, economical, and reproducible for determining IgM concentrations than enzyme-linked immunosorbent assay. Additionally, we normalized antibody array data for six serum proteins using the median-centered/IgM-TIS assay, and evaluated serum biomarkers through distribution analysis of normalized fluorescence intensities and receiver operating characteristic analyses for the diagnosis of liver cirrhosis and HCC. Apolipoprotein A-1 and a combination of alpha-fetoprotein and C-reactive protein were determined to be potential serological biomarkers for liver cirrhosis and HCC, respectively. Thus, median-centered/IgM-TIS assay normalization is a useful approach for analyzing antibody array data and evaluating serological biomarkers for the diagnosis of liver disease or cancers.

Original languageEnglish
Pages (from-to)92-98
Number of pages7
JournalAnalytica Chimica Acta
Volume718
DOIs
Publication statusPublished - 2012 Mar 9

Fingerprint

Biomarkers
Liver
antibody
Immunoglobulin M
biomarker
Liver Diseases
Assays
assay
serum
Antibodies
Liver Cirrhosis
protein
Blood Proteins
Serum
Immunosorbents
Apolipoprotein A-I
alpha-Fetoproteins
Liver Neoplasms
ROC Curve
C-Reactive Protein

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Biochemistry
  • Environmental Chemistry
  • Spectroscopy

Cite this

Kong, Deok Hoon ; Jung, Jae Wan ; Na, Keun ; Jeong, Seul Ki ; Paik, Young Ki ; Jung, Se Hui ; Suh, In Bum ; Kim, Young Myeong ; Ha, Kwon Soo. / Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease. In: Analytica Chimica Acta. 2012 ; Vol. 718. pp. 92-98.
@article{e446f1c7ef4547dc9cbabc028577b335,
title = "Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease",
abstract = "For minimizing systemic experimental variation in the analysis of antibody array data, we developed a novel median-centered/IgM-tagged-internal standard (TIS) assay normalization using median-centering and TIS assay-based determination of serum IgM concentrations. We evaluated five normalization methods by analyzing correlation coefficients and coefficients of variation for six serum proteins using human serum samples from normal controls (n= 25) and patients with liver cirrhosis (n= 25) or hepatocellular carcinoma (HCC; n= 29). Median-centered normalization improved correlation coefficients, while IgM-based normalizations improved coefficients of variation. The TIS assay was more efficient, economical, and reproducible for determining IgM concentrations than enzyme-linked immunosorbent assay. Additionally, we normalized antibody array data for six serum proteins using the median-centered/IgM-TIS assay, and evaluated serum biomarkers through distribution analysis of normalized fluorescence intensities and receiver operating characteristic analyses for the diagnosis of liver cirrhosis and HCC. Apolipoprotein A-1 and a combination of alpha-fetoprotein and C-reactive protein were determined to be potential serological biomarkers for liver cirrhosis and HCC, respectively. Thus, median-centered/IgM-TIS assay normalization is a useful approach for analyzing antibody array data and evaluating serological biomarkers for the diagnosis of liver disease or cancers.",
author = "Kong, {Deok Hoon} and Jung, {Jae Wan} and Keun Na and Jeong, {Seul Ki} and Paik, {Young Ki} and Jung, {Se Hui} and Suh, {In Bum} and Kim, {Young Myeong} and Ha, {Kwon Soo}",
year = "2012",
month = "3",
day = "9",
doi = "10.1016/j.aca.2011.12.055",
language = "English",
volume = "718",
pages = "92--98",
journal = "Analytica Chimica Acta",
issn = "0003-2670",
publisher = "Elsevier",

}

Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease. / Kong, Deok Hoon; Jung, Jae Wan; Na, Keun; Jeong, Seul Ki; Paik, Young Ki; Jung, Se Hui; Suh, In Bum; Kim, Young Myeong; Ha, Kwon Soo.

In: Analytica Chimica Acta, Vol. 718, 09.03.2012, p. 92-98.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease

AU - Kong, Deok Hoon

AU - Jung, Jae Wan

AU - Na, Keun

AU - Jeong, Seul Ki

AU - Paik, Young Ki

AU - Jung, Se Hui

AU - Suh, In Bum

AU - Kim, Young Myeong

AU - Ha, Kwon Soo

PY - 2012/3/9

Y1 - 2012/3/9

N2 - For minimizing systemic experimental variation in the analysis of antibody array data, we developed a novel median-centered/IgM-tagged-internal standard (TIS) assay normalization using median-centering and TIS assay-based determination of serum IgM concentrations. We evaluated five normalization methods by analyzing correlation coefficients and coefficients of variation for six serum proteins using human serum samples from normal controls (n= 25) and patients with liver cirrhosis (n= 25) or hepatocellular carcinoma (HCC; n= 29). Median-centered normalization improved correlation coefficients, while IgM-based normalizations improved coefficients of variation. The TIS assay was more efficient, economical, and reproducible for determining IgM concentrations than enzyme-linked immunosorbent assay. Additionally, we normalized antibody array data for six serum proteins using the median-centered/IgM-TIS assay, and evaluated serum biomarkers through distribution analysis of normalized fluorescence intensities and receiver operating characteristic analyses for the diagnosis of liver cirrhosis and HCC. Apolipoprotein A-1 and a combination of alpha-fetoprotein and C-reactive protein were determined to be potential serological biomarkers for liver cirrhosis and HCC, respectively. Thus, median-centered/IgM-TIS assay normalization is a useful approach for analyzing antibody array data and evaluating serological biomarkers for the diagnosis of liver disease or cancers.

AB - For minimizing systemic experimental variation in the analysis of antibody array data, we developed a novel median-centered/IgM-tagged-internal standard (TIS) assay normalization using median-centering and TIS assay-based determination of serum IgM concentrations. We evaluated five normalization methods by analyzing correlation coefficients and coefficients of variation for six serum proteins using human serum samples from normal controls (n= 25) and patients with liver cirrhosis (n= 25) or hepatocellular carcinoma (HCC; n= 29). Median-centered normalization improved correlation coefficients, while IgM-based normalizations improved coefficients of variation. The TIS assay was more efficient, economical, and reproducible for determining IgM concentrations than enzyme-linked immunosorbent assay. Additionally, we normalized antibody array data for six serum proteins using the median-centered/IgM-TIS assay, and evaluated serum biomarkers through distribution analysis of normalized fluorescence intensities and receiver operating characteristic analyses for the diagnosis of liver cirrhosis and HCC. Apolipoprotein A-1 and a combination of alpha-fetoprotein and C-reactive protein were determined to be potential serological biomarkers for liver cirrhosis and HCC, respectively. Thus, median-centered/IgM-TIS assay normalization is a useful approach for analyzing antibody array data and evaluating serological biomarkers for the diagnosis of liver disease or cancers.

UR - http://www.scopus.com/inward/record.url?scp=84862798143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862798143&partnerID=8YFLogxK

U2 - 10.1016/j.aca.2011.12.055

DO - 10.1016/j.aca.2011.12.055

M3 - Article

C2 - 22305903

AN - SCOPUS:84862798143

VL - 718

SP - 92

EP - 98

JO - Analytica Chimica Acta

JF - Analytica Chimica Acta

SN - 0003-2670

ER -